Last 47 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -77.39 | — | — | — | 260.94 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 3.47 | 4.24 | 4.36 | 4.81 | 7.08 | 7.17 | 6.60 | 5.21 | 4.30 | 3.93 | 5.66 | 6.82 | 6.20 | 5.79 | 6.41 | 8.43 | 6.27 | 9.06 | 7.90 | 12.61 | 10.59 |
| — | -40.8% | -33.8% | -7.7% | +64.6% | +82.4% | +16.5% | -23.6% | -30.7% | -32.1% | -11.7% | -19.1% | -1.1% | -36.1% | -18.9% | -33.2% | -40.8% | +79.9% | +32.0% | -7.4% | -51.4% | |
| P/B Ratio | 18.90 | 21.24 | 21.04 | 23.80 | 38.72 | 45.39 | 47.51 | 38.16 | 31.09 | 32.34 | 33.80 | 39.87 | 15.64 | 13.13 | 14.21 | 16.94 | 11.78 | 15.74 | 13.18 | 19.03 | 12.40 |
| — | -53.2% | -55.7% | -37.6% | +24.5% | +40.4% | +40.6% | -4.3% | +98.8% | +146.4% | +137.8% | +135.4% | +32.8% | -16.6% | +7.9% | -11.0% | -5.0% | +170.5% | +107.6% | +45.5% | -38.3% | |
| P/FCF | 401.69 | — | 26.08 | — | 102.05 | 68.98 | 71.21 | — | 57.03 | 37.40 | 250.03 | — | — | — | — | — | 128.77 | — | — | — | — |
| — | — | -63.4% | — | +78.9% | +84.4% | -71.5% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | 260.90 | — | 103.42 | 573.72 | — | — | 311.73 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | -66.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | 377.06 | — | 171.42 | — | — | — | 367.58 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | -53.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.6% | 74.2% | 72.8% | 70.9% | 70.9% | 71.1% | 71.2% | 68.8% | 70.0% | 68.8% | 69.9% | 66.3% | 66.0% | 66.2% | 69.5% | 67.9% | 69.9% | 68.3% | 68.8% | 66.9% | 62.7% |
| — | +4.4% | +2.3% | +3.0% | +1.2% | +3.4% | +1.8% | +3.8% | +6.1% | +3.9% | +0.6% | -2.3% | -5.6% | -3.1% | +0.9% | +1.6% | +11.5% | +3.9% | +1.2% | -2.3% | -15.3% | |
| Operating Margin | -4.9% | -14.7% | -1.1% | -5.9% | 4.2% | -2.1% | -7.8% | -20.3% | -2.5% | -34.1% | -15.5% | -28.9% | -29.6% | -22.2% | -15.2% | -35.4% | -18.4% | -20.3% | -23.0% | -52.6% | -39.4% |
| — | -608.1% | +85.4% | +70.8% | +268.9% | +93.9% | +49.9% | +29.7% | +91.6% | -53.9% | -2.1% | +18.5% | -60.9% | -9.1% | +33.8% | +32.5% | +53.3% | +25.5% | -9.9% | -42.2% | -223.8% | |
| Net Margin | -6.0% | -13.5% | -0.2% | -7.0% | 2.7% | -2.7% | -7.6% | -19.3% | -0.8% | -31.3% | -13.6% | -34.6% | -29.2% | -21.8% | -14.9% | -35.1% | -17.9% | -20.7% | -23.4% | -54.8% | -39.7% |
| — | -398.5% | +97.8% | +63.9% | +429.2% | +91.4% | +43.9% | +44.1% | +97.2% | -43.8% | +8.8% | +1.4% | -62.8% | -5.4% | +36.4% | +35.9% | +54.8% | +25.7% | -9.6% | -46.6% | -224.3% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -36.6% | -16.4% | -0.2% | -8.9% | 4.1% | -4.6% | -14.9% | -34.6% | -1.6% | -54.0% | -21.2% | -30.4% | -18.0% | -12.2% | -8.3% | -16.9% | -8.4% | -8.9% | -9.8% | -19.3% | -11.3% |
| — | -255.8% | +98.5% | +74.3% | +347.9% | +91.4% | +29.6% | -13.7% | +90.9% | -342.0% | -155.9% | -79.5% | -113.5% | -37.9% | +15.1% | +12.2% | +25.3% | -12.5% | -73.2% | -126.3% | -295.6% | |
| ROA | -4.6% | -2.7% | -0.0% | -1.4% | 0.6% | -0.5% | -1.5% | -3.3% | -0.1% | -5.1% | -2.2% | -6.8% | -8.9% | -6.2% | -4.3% | -9.0% | -4.5% | -4.9% | -5.5% | -11.4% | -6.9% |
| — | -413.6% | +97.6% | +58.4% | +482.4% | +89.5% | +31.6% | +51.4% | +98.4% | +19.1% | +49.4% | +24.4% | -95.0% | -27.4% | +21.5% | +20.8% | +34.0% | +0.4% | -53.5% | -102.3% | -260.1% | |
| ROIC | -5.2% | -4.2% | -0.3% | -1.4% | 1.1% | -0.5% | -2.2% | -5.7% | -0.9% | -13.2% | -5.8% | -9.4% | -9.7% | -7.0% | -4.8% | -10.0% | -5.3% | -5.5% | -6.3% | -13.2% | -9.1% |
| — | -681.5% | +87.0% | +75.8% | +219.8% | +96.0% | +61.7% | +39.6% | +90.9% | -89.5% | -21.7% | +6.4% | -83.6% | -25.7% | +24.2% | +24.1% | +42.1% | +11.6% | -48.2% | -116.5% | -374.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 4.79 | 4.10 | 3.91 | 4.52 | 4.79 | 6.01 | 7.09 | 8.49 | 8.11 | 10.25 | 7.43 | 8.16 | 0.62 | 0.60 | 0.58 | 0.59 | 0.55 | 0.54 | 0.54 | 0.54 | 0.42 |
| — | -31.9% | -44.8% | -46.7% | -40.9% | -41.3% | -4.5% | +4.0% | +1211.8% | +1609.6% | +1185.9% | +1282.4% | +13.1% | +10.9% | +7.7% | +8.9% | +29.8% | +20.9% | +26.6% | +30.0% | +17.5% | |
| Debt / EBITDA | — | — | 172.77 | — | 47.19 | 279.88 | — | — | 292.31 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | -83.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 4.63 | 3.57 | 3.87 | 5.17 | 4.63 | 4.63 | 5.02 | 5.71 | 5.82 | 6.27 | 6.92 | 7.10 | 2.15 | 2.29 | 2.71 | 3.10 | 3.24 | 3.42 | 4.04 | 4.63 | 3.48 |
| — | -22.9% | -23.0% | -9.6% | -20.5% | -26.2% | -27.4% | -19.5% | +170.8% | +173.9% | +155.6% | +129.0% | -33.7% | -33.0% | -33.0% | -33.1% | -6.8% | -12.9% | -12.0% | -18.1% | -39.6% | |
| Quick Ratio | 4.48 | 3.45 | 3.75 | 4.98 | 4.48 | 4.50 | 4.88 | 5.58 | 5.70 | 6.12 | 6.76 | 6.95 | 2.02 | 2.16 | 2.55 | 2.90 | 3.07 | 3.25 | 3.84 | 4.43 | 3.36 |
| — | -23.2% | -23.2% | -10.7% | -21.3% | -26.6% | -27.8% | -19.6% | +182.0% | +183.8% | +165.6% | +139.5% | -34.2% | -33.6% | -33.7% | -34.6% | -8.6% | -14.7% | -14.1% | -20.0% | -40.8% | |
| Interest Coverage | -2.31 | -8.05 | 0.88 | -3.08 | 2.81 | -0.58 | -3.39 | -8.18 | 0.64 | -12.82 | -5.01 | -14.96 | -39.85 | -28.04 | -20.96 | -40.08 | -18.87 | -33.75 | -48.51 | -23.92 | -129.77 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying IRTC stock.
iRhythm Technologies, Inc.'s current P/E is -77.4x. The average P/E over the last 1 quarters is 260.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
iRhythm Technologies, Inc.'s current operating margin is -4.9%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking iRhythm Technologies, Inc.'s business trajectory between earnings reports.